Stockreport

Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine

Psyence Biomedical Ltd. - Common Shares  (PBM) 
PDF NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company adva [Read more]